about
Patterns of soil-transmitted helminth infection and impact of four-monthly albendazole treatments in preschool children from semi-urban communities in Nigeria: a double-blind placebo-controlled randomised trialGenomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort.Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: a double-blind placebo-controlled randomized trialIdentification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria.AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.Ascaris co-infection does not alter malaria-induced anaemia in a cohort of Nigerian preschool children.Monitoring clinical trials: a practical guide.Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis.Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review.Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled TrialEffect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitisAMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialLeave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countriesAddition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysisDynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitisHealthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
P50
Q33410669-22230F25-1231-41D9-910B-0067E1C9B467Q33626075-618F5387-9D88-4B9A-B96E-AB086CD00152Q33698684-4F58F2E4-31A7-4F18-9B64-A7CB1CF76C8CQ33749757-CC4F2D85-2648-4D17-8413-F5E2162BA634Q35776693-1171ABD9-9515-47B3-AD4B-6DF12266AD64Q36531272-C3C8BFC1-5AE0-4FA0-8FC4-451682B71CB6Q38955164-91FB5138-1D7D-44D9-9D58-9C296FEF4C53Q41637386-764BE80F-D446-42C8-B64C-48446766E0B5Q50064973-8056D092-7B91-413E-9EB5-AAFE28A9571FQ54255992-9BE53428-338B-4716-A032-6646D75C3F5EQ57518407-85A94A52-4298-4F83-B008-9221F6F274A0Q58718306-E678E0A7-72A8-40DA-B928-2DEC9A481F6BQ59333131-646E07E1-4B01-45A6-A8FF-126C3629D736Q60364337-C116BA6C-25F1-4089-AED5-FA0B57CF6EF5Q62486624-38A31CDF-85B3-4235-A2E7-C7ED4B59AA22Q64229904-2DC381D3-7AAB-4E46-AB46-77B8E81D2B26Q92317213-817F6455-C094-491D-8118-E7DA70201794
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Síle F Molloy
@ast
Síle F Molloy
@en
Síle F Molloy
@es
Síle F Molloy
@nl
type
label
Síle F Molloy
@ast
Síle F Molloy
@en
Síle F Molloy
@es
Síle F Molloy
@nl
prefLabel
Síle F Molloy
@ast
Síle F Molloy
@en
Síle F Molloy
@es
Síle F Molloy
@nl
P108
P31
P496
0000-0001-8847-2325